Eisai Co., Ltd. (4523.T)
JPY 4072.0
(0.84%)
JPY 4072.0
(0.84%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 42.4 Billion JPY | -23.5% |
| 2022 | 55.43 Billion JPY | 15.59% |
| 2021 | 47.95 Billion JPY | 14.33% |
| 2020 | 41.94 Billion JPY | -65.56% |
| 2019 | 121.76 Billion JPY | 92.1% |
| 2018 | 63.38 Billion JPY | 22.26% |
| 2017 | 51.84 Billion JPY | 31.72% |
| 2016 | 39.35 Billion JPY | -28.35% |
| 2015 | 54.93 Billion JPY | 27.01% |
| 2014 | 43.25 Billion JPY | 31.25% |
| 2013 | 32.95 Billion JPY | -31.73% |
| 2012 | 48.27 Billion JPY | -17.49% |
| 2011 | 58.51 Billion JPY | -13.18% |
| 2010 | 67.39 Billion JPY | 67.07% |
| 2009 | 40.33 Billion JPY | -15.39% |
| 2008 | 47.67 Billion JPY | 380.26% |
| 2007 | -17.01 Billion JPY | -124.09% |
| 2006 | 70.61 Billion JPY | 11.36% |
| 2005 | 63.41 Billion JPY | 14.24% |
| 2004 | 55.5 Billion JPY | 10.68% |
| 2003 | 50.14 Billion JPY | 22.23% |
| 2002 | 41.02 Billion JPY | 11.49% |
| 2001 | 36.79 Billion JPY | 57.79% |
| 2000 | 23.32 Billion JPY | 106.85% |
| 1999 | 11.27 Billion JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 10.58 Billion JPY | -20.5% |
| 2023 Q2 | 2.78 Billion JPY | -86.29% |
| 2023 FY | 42.4 Billion JPY | -23.5% |
| 2023 Q4 | 13.3 Billion JPY | 122.97% |
| 2023 Q3 | 5.96 Billion JPY | 114.02% |
| 2023 Q1 | 20.34 Billion JPY | 24.61% |
| 2022 FY | 55.43 Billion JPY | 15.59% |
| 2022 Q2 | 3.56 Billion JPY | -86.74% |
| 2022 Q3 | 8.64 Billion JPY | 142.26% |
| 2022 Q4 | 16.32 Billion JPY | 88.84% |
| 2022 Q1 | 26.89 Billion JPY | 316.85% |
| 2021 FY | 47.95 Billion JPY | 14.33% |
| 2021 Q2 | 4.02 Billion JPY | -90.46% |
| 2021 Q1 | 42.16 Billion JPY | 1483.69% |
| 2021 Q3 | 14.17 Billion JPY | 252.21% |
| 2021 Q4 | -12.4 Billion JPY | -187.52% |
| 2020 Q1 | 24.42 Billion JPY | -49.66% |
| 2020 FY | 41.94 Billion JPY | -65.56% |
| 2020 Q2 | 1.37 Billion JPY | -94.39% |
| 2020 Q4 | -3.04 Billion JPY | -115.73% |
| 2020 Q3 | 19.37 Billion JPY | 1312.84% |
| 2019 Q3 | 46.25 Billion JPY | 768.86% |
| 2019 FY | 121.76 Billion JPY | 92.1% |
| 2019 Q1 | 21.67 Billion JPY | -7.42% |
| 2019 Q4 | 48.51 Billion JPY | 4.88% |
| 2019 Q2 | 5.32 Billion JPY | -75.43% |
| 2018 Q4 | 23.4 Billion JPY | 219.65% |
| 2018 Q2 | 20.34 Billion JPY | 65.33% |
| 2018 Q1 | 12.3 Billion JPY | -48.15% |
| 2018 Q3 | 7.32 Billion JPY | -64.01% |
| 2018 FY | 63.38 Billion JPY | 22.26% |
| 2017 FY | 51.84 Billion JPY | 31.72% |
| 2017 Q3 | 9.29 Billion JPY | 3.06% |
| 2017 Q2 | 9.01 Billion JPY | -8.08% |
| 2017 Q1 | 9.8 Billion JPY | 943.19% |
| 2017 Q4 | 23.73 Billion JPY | 155.49% |
| 2016 Q2 | 8.17 Billion JPY | -58.61% |
| 2016 FY | 39.35 Billion JPY | -28.35% |
| 2016 Q3 | 10.51 Billion JPY | 28.64% |
| 2016 Q1 | 19.73 Billion JPY | 18.82% |
| 2016 Q4 | 940 Million JPY | -91.06% |
| 2015 Q1 | 5.44 Billion JPY | -17.03% |
| 2015 Q2 | 5.58 Billion JPY | 2.59% |
| 2015 Q4 | 16.61 Billion JPY | -39.13% |
| 2015 Q3 | 27.29 Billion JPY | 388.56% |
| 2015 FY | 54.93 Billion JPY | 27.01% |
| 2014 Q1 | 5.67 Billion JPY | 63.99% |
| 2014 Q4 | 6.56 Billion JPY | -75.02% |
| 2014 Q2 | 4.73 Billion JPY | -16.64% |
| 2014 Q3 | 26.27 Billion JPY | 455.07% |
| 2014 FY | 43.25 Billion JPY | 31.25% |
| 2013 Q2 | 18.1 Billion JPY | 92.41% |
| 2013 FY | 32.95 Billion JPY | -31.73% |
| 2013 Q4 | 3.46 Billion JPY | 233.6% |
| 2013 Q3 | -2.59 Billion JPY | -114.32% |
| 2013 Q1 | 9.4 Billion JPY | -34.04% |
| 2012 Q3 | 9.53 Billion JPY | -24.39% |
| 2012 Q4 | 14.26 Billion JPY | 49.64% |
| 2012 Q1 | 11.87 Billion JPY | 27.38% |
| 2012 FY | 48.27 Billion JPY | -17.49% |
| 2012 Q2 | 12.6 Billion JPY | 6.19% |
| 2011 Q4 | 9.32 Billion JPY | -41.25% |
| 2011 Q2 | 19.82 Billion JPY | 46.77% |
| 2011 FY | 58.51 Billion JPY | -13.18% |
| 2011 Q1 | 13.5 Billion JPY | 58617.39% |
| 2011 Q3 | 15.86 Billion JPY | -19.96% |
| 2010 Q1 | 18.78 Billion JPY | 238.35% |
| 2010 Q4 | 23 Million JPY | -99.92% |
| 2010 FY | 67.39 Billion JPY | 67.07% |
| 2010 Q3 | 27.42 Billion JPY | 29.59% |
| 2010 Q2 | 21.16 Billion JPY | 12.62% |
| 2009 Q3 | 22.99 Billion JPY | 57.8% |
| 2009 Q4 | -13.58 Billion JPY | -159.06% |
| 2009 FY | 40.33 Billion JPY | -15.39% |
| 2009 Q1 | 16.34 Billion JPY | 92.18% |
| 2009 Q2 | 14.57 Billion JPY | -10.86% |
| 2008 Q3 | 10.45 Billion JPY | -13.4% |
| 2008 FY | 47.67 Billion JPY | 380.26% |
| 2008 Q1 | 16.63 Billion JPY | 0.0% |
| 2008 Q2 | 12.07 Billion JPY | -27.41% |
| 2008 Q4 | 8.5 Billion JPY | -18.66% |
| 2007 FY | -17.01 Billion JPY | -124.09% |
| 2006 FY | 70.61 Billion JPY | 11.36% |
| 2005 FY | 63.41 Billion JPY | 14.24% |
| 2004 FY | 55.5 Billion JPY | 10.68% |
| 2003 FY | 50.14 Billion JPY | 22.23% |
| 2002 FY | 41.02 Billion JPY | 11.49% |
| 2001 FY | 36.79 Billion JPY | 57.79% |
| 2000 FY | 23.32 Billion JPY | 106.85% |
| 1999 FY | 11.27 Billion JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 3.2 Billion JPY | -1223.151% |
| Takeda Pharmaceutical Company Limited | 144.06 Billion JPY | 70.564% |
| Sumitomo Pharma Co., Ltd. | -314.96 Billion JPY | 113.464% |
| Shionogi & Co., Ltd. | 162.03 Billion JPY | 73.828% |
| Wakamoto Pharmaceutical Co.,Ltd. | 108.95 Million JPY | -38820.144% |
| Nippon Shinyaku Co., Ltd. | 25.85 Billion JPY | -64.044% |
| Kaken Pharmaceutical Co., Ltd. | 8.02 Billion JPY | -428.436% |
| Morishita Jintan Co., Ltd. | 697 Million JPY | -5984.218% |
| Hisamitsu Pharmaceutical Co., Inc. | 13.96 Billion JPY | -203.579% |
| Mochida Pharmaceutical Co., Ltd. | 4.54 Billion JPY | -832.637% |
| Fuso Pharmaceutical Industries,Ltd. | 1.37 Billion JPY | -2979.666% |
| Nippon Chemiphar Co., Ltd. | -180 Million JPY | 23659.444% |
| Tsumura & Co. | 16.7 Billion JPY | -153.828% |
| Kissei Pharmaceutical Co., Ltd. | 11.16 Billion JPY | -279.991% |
| Torii Pharmaceutical Co., Ltd. | 4.11 Billion JPY | -929.546% |
| Towa Pharmaceutical Co., Ltd. | 16.17 Billion JPY | -162.209% |
| Fuji Pharma Co., Ltd. | 3.43 Billion JPY | -1134.556% |
| Zeria Pharmaceutical Co., Ltd. | 7.73 Billion JPY | -448.513% |
| KYORIN Holdings, Inc. | 5.32 Billion JPY | -696.825% |
| Taiko Pharmaceutical Co.,Ltd. | -4.89 Billion JPY | 966.51% |
| Daito Pharmaceutical Co.,Ltd. | 3.29 Billion JPY | -1187.011% |
| SymBio Pharmaceuticals Limited | -1.96 Billion JPY | 2260.517% |
| MedRx Co., Ltd | -932 Million JPY | 4650.107% |
| Mizuho Medy Co.,Ltd. | 3.77 Billion JPY | -1023.591% |
| Solasia Pharma K.K. | -1.11 Billion JPY | 3913.579% |
| Modalis Therapeutics Corporation | -2.39 Billion JPY | 1873.001% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 7.54 Billion JPY | -462.054% |
| Sawai Group Holdings Co., Ltd. | 13.69 Billion JPY | -209.653% |
| Cyfuse Biomedical K.K. | -589.21 Million JPY | 7297.252% |
| Toho Holdings Co., Ltd. | 20.65 Billion JPY | -105.291% |
| Koa Shoji Holdings Co.,Ltd. | 2.94 Billion JPY | -1339.313% |